Annals ofRheumatoid Arthritis

Volume: 1 - Number: 1 - July 15, 2003

Diabetes e Incretinas

Contribution's and Articles

Amelioration of collagen-induced arthritis by thrombin inhibition

Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis

Amelioration of Collagen-induced Arthritis by CD95 (Apo-1/Fas)-ligand Gene Transfer

AIP1 mediates TNF-–induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-4

Advances in Immunology: Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia

A proinflammatory role for IL-18 in rheumatoid arthritis

A GNAS1 imprinting defect in pseudohypoparathyroidism type IB

A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor

A full complement of receptors in immune complex

A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality

15-deoxy-12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

That impish TIMP: the tissue inhibitor of metalloproteinases-4

The maternal-neonatal neuro-immune interface: Are there long-term implications for inflammatory or stress-related disease?

T cell homeostasis and systemic autoimmunity

Series Introduction: Autoimmune diseases: are markers ready for prediction?

Petulant cellular acts: destroying the ECM rather than creating it

Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences

Short-circuiting long-lived humoral immunity by the heightened engagement of CD40

Diabetes e Incretinas

Editorial

Ankylosing Spondylitis: What Do We Really Know About the Onset and Progression of This Disease?

Can Progression of Radiographic Joint Damage Be Predicted Early in Rheumatoid Arthritis?

Pharmacology and Therapeutics

FDA: Parte II. Licencia de aplicación biológica del adalimumab, un bloqueador del TNF-alfa, totalmente humanizado, en las artritis graves de base inflamatoria y autoinmune

FDA: Parte I Licencia de aplicación biológica del adalimumab, un bloqueador del TNF-alfa, totalmente humanizado, en las graves artritis de base inflamatoria y autoinmune

Seguimos creciendo para Brindar el mejor servicio

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...